20918 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Methods of inhibiting integrin α9β1 activity
#1202Oligonucleotides for reduction of PD-L1 expression
#1203HUMAN SKIN EQUIVALENTS EXPRESSING EXOGENOUS POLYPEPTIDES
#1204Phosphorothioate-conjugated peptides and methods of using the same
#1205Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors
#1206C3B binding polypeptide
#1207APOMERS
#1208DYSTROPHIN GLYCOPROTEIN COMPLEX SEQUESTERS YAP TO INHIBIT CARDIOMYOCYTE PROLIFERATION
#1209Treatment of angiogenesis disorders
#1210Removal of serine proteases by treatment with finely divided silicon dioxide
#1211TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER EYE DISEASES WITH APOLIPOPROTEIN MIMETICS
#1212NNIF and nNIF-related peptides and related methods
#1213TREATMENT OF TINNITUS THROUGH MODULATION OF CHLORIDE CO-TRANSPORTER NKCC1 IN THE AUDITORY SYSTEM
#1214TRPV3 agonists for the treatment of skin conditions
#1215Production of recombinant lubricin
#1216COMPOSITION FOR IMPROVING SKIN CONDITIONS COMPRISING A FRAGMENT OF HUMAN HEAT SHOCK PROTEIN 90A AS AN ACTIVE INGREDIENT
#1217PHARMACEUTICAL COMPOSITIONS AND USE THEREOF FOR RELIEVING RESISTANCE DUE TO CANCER CHEMOTHERAPY AND ENHANCING EFFECT OF CANCER CHEMOTHERAPY
#1218Formulations and methods of use for alpha connexin c-terminal (ACT) peptides
#1219Methods for treating huntington's disease using a polynucleotide encoding a VTFT isoform of a BPIFB4 protein
#1220Compositions and methods to improve exercise performance and recovery
#1221Methods for treating cardiac conditions
#1222Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain
#1223COMPOSITIONS AND METHODS FOR TREATING SPINAL MUSCULAR ATROPHY
#1224MIXED-LINEAGE KINASE DOMAIN-LIKE PROTEIN IN IMMUNOTHERAPEUTIC CANCER CONTROL
#1225GLA DOMAINS AS TARGETING AGENTS
#1226Polypeptide-polymer conjugates and methods of use thereof
#1227Cationic polymers
#1228Annelid haemoglobin lyophilisation process
#1229Nanofibrous scaffolds to heal chronic skin wounds
#1230Methods of treating cognitive impairment
#1231BIO-MIMETIC FORMULATION
#1232Compositions, methods and uses of messenger RNA
#1233Saposin-A derived peptides and uses thereof
#1234COMPOSITIONS AND METHODS FOR NUCLEIC ACID TRANSFER
#1235Intrathecal Delivery of Recombinant Adeno-Associated Virus 9
#1236Methods for diagnosing and treating Alzheimer's disease
#1237Immunoglobulins and uses thereof
#1238Bioactive polymer for bone regeneration
#1239Method
#1240Polypeptide for use in the protection of oxygen sensitive gram-positive bacteria
#1241VESICLE-ENCAPSULATED SOCS
#1242TRANSDUCTION BUFFER
#1243MPS PEPTIDES AND USE THEREOF
#1244COMPOSITIONS AND METHODS FOR DELIVERING CFTR POLYPEPTIDES
#1245Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5
#1246METHOD FOR OPENING TIGHT JUNCTIONS
#1247TOPICAL DELIVERY OF THERAPEUTIC AGENTS USING CELL-PENETRATING PEPTIDES FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER EYE DISEASES
#1248COMPOSITIONS AND METHODS USING A COMBINATION OF AUTOPHAGY INDUCER AND HIGH PROTEIN FOR INDUCTION OF AUTOPHAGY
#1249SYSTEMS AND METHODS FOR LOCAL MODULATION OF WNT SIGNALING
#1250Compositions comprising chemotherapeutic agents and checkpoint inhibitors and methods of use
#1251MUTANT ADENO-ASSOCIATED VIRUS VIRIONS AND METHODS OF USE THEREOF
#1252Constructs having a SIRP-alpha domain or variant thereof
#1253Target for diabetes treatment and prevention
#1254Treatment of pyroptosis
#1255Serum response factor regenerates senescent cells
#1256MODIFIED BINDING PROTEINS INHIBITING THE VEGF-A RECEPTOR INTERACTION
#1257A CLINICAL MANAGEMENT PROTOCOL
#1258Methods and compositions for treating Huntington's Disease
#1259Method for treating cerebral stroke
#1260Processes for making and using a mesenchymal stem cell derived secretome
#1261Anionic nanocomplexes for nucleic acid delivery
#1262VIRAL VECTORS FOR THE TREATMENT OF RETINAL DYSTROPHY
#1263Materials and methods for treating Friedreich's Ataxia
#1264Gram-negative lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof in human serum
#1265Macrophage stimulating 1 receptor (MST1R) variants and uses thereof
#1266ALTERING INFLAMMATORY STATES OF IMMUNE CELLS IN VIVO BY MODULATING CELLULAR ACTIVATION STATES
#1267Heparin-Associated Polypeptides and Uses Thereof
#1268Mutant NGAL proteins and uses thereof
#1269METHODS FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
#1270Materials and methods for modulating t cell mediated immunity
#1271RNA preparations comprising purified modified RNA for reprogramming cells
#1272Administering methylation-controlled J protein (MCJ) SIRNA to a kidney cell
#1273Peptides and related compositions and methods
#1274METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY
#1275METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
#1276METHOD FOR PRODUCING COMPOSITION CONTAINING K-CASEIN GLYCOMACROPEPTIDE
#1277GLA DOMAINS AS THERAPEUTIC AGENTS
#1278Modular Particulars for Immunotherapy
#1279SOLUBLE FGFR3 DECOYS FOR TREATING SKELETAL GROWTH DISORDERS
#1280PEPTIDES FOR TREATMENT OF DIABETES
#1281CHELATING MOLECULES
#1282METHODS AND COMPOSITIONS FOR IMPROVED HOMOLOGY DIRECTED REPAIR
#1283Wnt compositions and methods for purification
#1284Targeting deregulated Wnt signaling in cancer using stabilized alpha-helices of BCL-9
#1285Peptide therapies for reduction of macular thickening
#1286NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE
#1287Fatty acids and their use in conjugation to biomolecules
#1288Composition comprising poly I:C and LAG-3-IGG fusion protein
#1289Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
#1290Method and system for reducing the likelihood of osteoporosis
#1291METHODS AND COMPOSITIONS FOR MRNA-BASED MODULATION AND DETECTION OF CELL PHENOTYPES
#1292RETINOL-BINDING PROTEIN 3 (RBP3) AS A PROTECTIVE FACTOR IN NON-DIABETIC RETINAL DEGENERATION
#1293A RECOMBINANT PROTEIN COMPRISING A DOUBLE STRANDED RNA BINDING DOMAIN
#1294Activin receptor type IIB variants and methods of use thereof
#1295COMBINATION OF A CYCLIN DEPENDENT KINASE INHIBITOR AND A BET- BROMODOMAIN INHIBITOR
#1296PROMOTING AND PROTECTING FUNCTIONAL BETA CELL MASS BY SYNTAXIN 4 ENRICHMENT
#1297Histatins and method of use thereof
#1298TREATING ROTATOR CUFF CONDITIONS
#1299SLIT AND BONE GROWTH MODULATION
#1300Reconstituted HDL formulation
#1301Compositions and methods for modulation of immune response
#1302Method and system for reducing the likelihood of developing depression in an individual
#1303THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c
#1304THE VOLUME-REGULATED ANION CHANNEL PROTEIN LRRC8A FOR USE IN ALTERING EPIDERMAL KERATINOCYTE DIFFERENTIATION
#1305Modulating Immune Responses
#1306METHODS AND COMPOSITIONS FOR TREATING GENETICALLY LINKED DISEASES OF THE EYE
#1307Methods for enhancing antigen-specific immune responses
#1308METHOD FOR INCREASING NEPRILYSIN EXPRESSION AND ACTIVITY
#1309Active peptide for enhancing the phagocytic functions of retinal pigment epithelium and a use thereof
#1310METHODS USING WHEY PROTEIN TO IMPROVE OR MAINTAIN MUSCLE QUALITY
#1311PROLIFERATION OF MUC1 EXPRESSING CELLS
#1312THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS
#1313Immunoglobulins and uses thereof
#1314GENE THERAPY FOR NEURODEGENERATIVE DISORDERS
#1315Compositions and methods for enhancing neuro-repair
#1316Therapeutic agent for inflammatory bowel disease
#1317MODIFIED FRIEDREICH ATAXIA GENES AND VECTORS FOR GENE THERAPY
#1318THERAPY OF IONIZING RADIATION-INDUCED DISORDERS
#1319Lipopeptides for Use in Treating Liver Diseases and Cardiovascular Diseases
#1320IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases
#1321Modified ligand-gated ion channels and methods of use
#1322Optimized mini-dystrophin genes and expression cassettes and their use
#1323LIPID NANO PARTICLE COMPLEX COMPRISING APTIDE FUSED WITH CELL PENETRATING MATERIALS AND USE SAME
#1324MANNOSE-6-PHOSPHATE BEARING PEPTIDES FUSED TO LYSOSOMAL ENZYMES
#1325Compositions of phosphorylated tau peptides and uses thereof
#1326USE OF CEREBROLYSIN
#1327Methods and Compounds for Treating Diabetes
#1328TREATMENT OF SPINAL MUSCULAR ATROPHY
#1329HISTAMINE-RELEASING FACTOR (HRF), HRF-RECEPTOR AND METHODS OF MODULATING INFLAMMATION
#1330Compositions and methods using a polyphenol for musculoskeletal health
#1331Compositions and methods for treating motor neuron diseases
#1332THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c
#1333Extraction of animal-derived pulmonary surfactants
#1334Pharmaceutical Composition Comprising an APL Type Peptide
#1335Prevention and/or treatment of hearing loss or impairment
#1336PIF-TRANSFECTED CELLS AND METHODS OF USE
#1337COMPOSITIONS AND METHODS FOR TREATING NEUROPSYCHIATRIC DISORDERS USING AN ENDOTHELIN-B RECEPTOR AGONIST
#1338Pharmacological Composition for Prevention or Treatment of Lupus, Comprising Mesenchymal Stem Cell-Derived Secretome
#1339Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
#1340DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY
#1341Rapamycin 40-O-cyclic hydrocarbon esters, compositions and methods
#1342EPICARDIAL-DERIVED PARACRINE FACTORS FOR REPAIRING CARDIAC TISSUE
#1343Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors
#1344Type I diabetes therapy
#1345Compositions and methods for the systemic treatment of arthritis
#1346Methods and compositions for modulating myofibroblast activities
#1347Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins
#1348GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#1349METHODS AND COMPOSITIONS RELATING TO P62 FOR THE TREATMENT AND PROPHYLAXIS OF CANCER
#1350EFFECT OF HEMOPEXIN THERAPY AFTER INTRACEREBRAL HEMORRHAGE
#1351BTNL9 and ERMAP as novel inhibitors of the immune system for immunotherapies
#1352Methods and compositions for regenerating hair cells and/or supporting cells
#1353Sensorineural hair cell differentiation
#1354Implants having a drug load of an oxysterol and methods of use
#1355COMPOSITIONS AND METHODS OF TREATING ALZHEIMER'S AND OTHER AMYLOID RELATED DISEASES
#1356GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#1357Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1358METHOD FOR MODULATING INSULIN-INDEPENDENT GLUCOSE TRANSPORT USING TENEURIN C-TERMINAL ASSOCIATED PEPTIDE (TCAP)
#1359Method for reducing the likelihood of developing cancer in an individual human being
#1360Processes for making and using a mesenchymal stem cell derived secretome
#1361Modification and Compositions of Human Secretoglobin Proteins
#1362METHODS AND COMPOSITIONS FOR REDUCING GUT ISCHEMIA/REPERFUSION-INDUCED INJURY
#1363Immunosuppressive agents and their use in therapy
#1364COMPOSITIONS AND METHODS OF TREATING CANCER
#1365Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#1366Compositions and methods for the treatment of malnutrition
#1367System and Method for the Production, Formulation and Use of Conditioned Media, Cultured Cells and the Factors Included Therein
#1368INHIBITORS OF IGFBP3 BINDING TO TMEM219 FOR TREATMENT OF INTESTINAL DISEASES
#1369Use of TREM-1 inhibitors for treatment, elimination and eradication of HIV-1 infection
#1370Muteins of human lipocalin 2 (Lcn2, hNGAL) with affinity for a given target
#1371Stapled intracellular-targeting antimicrobial peptides to treat infection
#1372TREATMENT OF AN ISCHEMIC HEART DISEASE
#1373Nutritive polypeptides and formulations thereof, and methods of production and use thereof
#1374TREATMENT OF EYE DISEASE
#1375Methods and compositions relating to chondrisomes from blood products
#1376Methods and compositions relating to chondrisomes from cultured cells
#1377Cell-permeable bone morphogenetic protein (CPBMP) recombinant protein and use thereof
#1378Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1379USE OF LINGO-4 ANTAGONISTS IN THE TREATMENT OF CONDITIONS INVOLVING DEMYELINATION
#1380ENHANCED DIRECT CARDIAC REPROGRAMMING
#1381TREATMENT OF AGE-RELATED AND MITOCHONDRIAL DISEASES BY INHIBITION OF HIF-1 ALPHA FUNCTION
#1382RP2 and RPGR vectors for treating X-linked retinitis pigmentosa
#1383Method for preparing a bone protein preparation and a bone protein preparation
#1384Compositions for treating heart disease by inhibiting the action of mAKAPβ
#1385Combined preparations of PKM2 modulators and HMGB1
#1386Drug delivery vehicles for atherosclerosis nanomedicine
#1387Targeted protein degradation
#1388Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#1389Compositions and method for reducing virulence of microorganisms
#1390Adhesion prevention material
#1391GLUCOCEREBROSIDE TREATMENT OF DISEASE
#1392PRESERVATION OF THE NEUROMUSCULAR JUNCTION AFTER TRAUMATIC NERVE INJURY
#1393Methods for treatment of and prophylaxis against inflammatory disorders
#1394SRPX for treatment of cancer
#1395Hydrogel toxin-absorbing or binding nanoparticles
#1396DIAGNOSIS AND TREATMENT OF MOTILITY DISORDERS OF THE GUT AND BLADDER, AND OF FIBROMYALGIA
#1397MECP2E1 GENE
#1398PREDICTING AGE-RELATED MACULAR DEGENERATION WITH SINGLE NUCLEOTIDE POLYMORPHISMS WITHIN OR NEAR THE GENES FOR COMPLEMENT COMPONENT C2, FACTOR B, PLEKHA1, HTRA1, PRELP, OR LOC387715
#1399Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
#1400Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#1401COMPOSITION FOR TREATING PULMONARY FIBROSIS AND EMPHYSEMA AND THERAPEUTIC METHOD USING THE SAME
#1402NORRIN INDUCED EXPRESSION OF GENES AND USE THEREOF TO TREAT DISEASE
#1403Therapeutic compositions
#1404Process of manufacture of annexin V
#1405C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
#1406CONTROLLED RELEASE SYSTEM FOR PULMONARY DELIVERY OF SURFACTANT PROTEIN D
#1407Use of actin depolymerizing agents for the treatment of anxiety disorders
#1408PROTECTIVE METALLOTHIONEIN ANALOG COMPOUNDS, THEIR COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF PATHOGENIC DISEASES
#1409ANTAGONISTS OF ACTRIIB AND USES FOR INCREASING RED BLOOD CELL LEVELS
#1410Compositions and methods for treating cancer
#1411Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy
#1412Compositions and methods for delivering CFTR polypeptides
#1413THERAPEUTIC AGENT OF UREMIA CONTAINING ALARIN AS THE MAIN INGREDIENT
#1414Pharmaceutical compositions and preparations for administration to the eye
#1415Oligonucleotides for reduction of PD-L1 expression
#1416Inhibition of autism spectrum disorder using decoy antigens to maternal brain-reactive antibodies
#1417IMPLANTS HAVING A HIGH DRUG LOAD OF AN OXYSTEROL AND METHODS OF USE
#1418Use of C-type natriuretic peptide variants to treat skeletal dysplasia
#1419Use of C-type natriuretic peptide variants to treat skeletal dysplasia
#1420COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF NEURODEGENERATIVE DISORDERS
#1421Treatments of Metabolic Disorders Using FGF Binding Protein 3
#1422PEPTIDES AND METHODS OF TRANSPLANTATION AND RESTORATIVE ORGAN FUNCTION
#1423Constructs having a SIRP-α domain or variant thereof
#1424Systems and methods for angiogenic treatment in wound healing
#1425METHODS AND DEVICES FOR PROMOTING NERVE GROWTH AND REGENERATION
#1426Combination Therapy of Fractionated Radiation and SAPC-DOPS for the Treatment of Tumors
#1427METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
#1428Hsp70 based combination therapy
#1429HEMOPEXIN FORMULATIONS
#1430Methods of decreasing amyloid beta (Aβ) plaque deposition and hyperphosphorylated tau plaque deposition in Alzheimer's disease using a cystatin C fusion protein
#1431Peptide inhibitors of twist
#1432Treatment and diagnosis of melanoma
#1433USE OF CD36 TO IDENTIFY CANCER SUBJECTS FOR TREATMENT
#1434HOMEOBOX TRANSCRIPTION FACTOR VENTX REGULATES DIFFERENTIATION AND MATURATION OF HUMAN DENDRITIC CELLS
#1435PREPARATION AND USE OF A PROTEIN-ENRICHED SOLUBLE FIBER COMPOSITION
#1436Methods and compositions for modulating appetite and intake of sodium
#1437Compositions and methods for treating diabetes, hypertension and hypercholesterolemia
#1438Method of Reducing Injury to Mammalian Cells
#1439Phosphoserine containing compositions for immune tolerance induction
#1440Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related Disorders
#1441Composition and methods for treatment of primary ciliary dyskinesia
#1442Compositions and methods for inhibiting intercellular interactions
#1443EXOSOMES AND METHODS OF USE THEREOF
#1444Anti-reflux infant nutrition
#1445PHARMACEUTICALS AND METHODS FOR TREATING HYPOXIA AND SCREENING METHODS THEREFOR
#1446Compositions and methods comprising bone morphogenetic protein and NEMO binding peptide
#1447Suppression of allergic lung inflammation and hyperreactivity
#1448ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MUSCLE SPECIFIC MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY
#1449Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
#1450Methods and compositions for regenerating tissues
#1451Complexes for treating sensitivity
#1452Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof
#1453Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof
#1454Recombinant klotho proteins and compositions and methods involving same
#1455Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
#1456Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
#1457Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and their use
#1458Beta-casein A2 and prevention of inflammation of the bowel
#1459THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANNEXIN A5
#1460Methods for regulating free fatty acid flux using fat specific protein 27 (FSP27) compositions
#1461COMPOSITION FOR AND METHOD OF FACILITATING CORNEAL TISSUE REPAIR
#1462Reducing the likelihood of skin cancer in an individual human being
#1463Neuronal viability factor and use thereof in Alzheimer's disease
#1464COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#1465MYB-RELATED TRANSCRIPTION FACTOR (MYPOP) AS DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR TUMOR THERAPY
#1466INHIBITION OF CARDIAC FIBROSIS IN MYOCARDIAL INFARCTION
#1467METHOD AND PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF DIABETES
#1468Reconstituted high density lipoprotein formulation and production method thereof
#1469THERAPEUTIC AGENT FOR DILATED CARDIOMYOPATHY
#1470Methods for inducing cell division of postmitotic cells
#1471GENES AND POLYMORPHISMS ASSOCIATED WITH AGE RELATED MACULAR DEGENERATION (AMD)
#1472Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#1473NANOVESICLES PRODUCED FROM MESENCHYMAL STROMAL CELLS FOR ANTI-INFLAMMATORY APPLICATIONS
#1474COMPOSITION FOR DELIVERING PHYSIOLOGICALLY ACTIVE INGREDIENTS INTO BLOOD VESSEL
#1475Ice-based lipid nanoparticle formulation for delivery of mRNA
#1476METHODS AND COMPOSITIONS FOR CANCER TREATMENT AND TREATMENT SELECTION
#1477Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1478Topically Active Steroids for Use in Radiation and Chemotherapeutics Injury
#1479HLA-G transcripts and isoforms and their uses
#1480Enhancement of osteogenic potential of bone grafts
#1481Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
#1482BETA-CASEIN A2 AND REDUCING OR PREVENTING SYMPTOMS OF LACTOSE INTOLERANCE
#1483USE OF CREG IN TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES
#1484Flattop (fltp) is a novel biomarker for beta cell maturation
#1485ApoC-II mimetic peptides
#1486Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload
#1487Nucleic acid molecules encoding human neutrophil gelatinase-associated lipocalin (hNGAL) which bind angiopoietin-2 (Ang-2)
#1488ALZHEIMER'S DISEASE TREATMENT METHOD
#1489Compositions comprising an urolithin compound
#1490Method of inducing cardiomyocytes proliferation and treating heart diseases
#1491SOCS1-DERIVED PEPTIDE FOR USE IN CHRONIC COMPLICATIONS OF DIABETES
#1492Clusterin for use in the treatment of thrombotic microangiopathies
#1493Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain
#1494Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity by UPF1
#1495Glycotargeting therapeutics
#1496BETA-CASEIN A2 AND BLOOD GLUCOSE LEVELS
#1497Method of treating knee pain
#1498Pharmaceutical composition containing ATPIF1 for treatment of diabetes
#1499Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
#1500DESMOCOLLIN 1 INHIBITORS FOR THE PREVENTION OR TREATMENT OF ATHEROSCLEROSIS